California is the first state in the country to partner with a nonprofit to develop, produce and sell its own insulin.

As of January, California is the first state in the country to partner with a nonprofit to develop, produce and sell its own ...

CivicaScript®, LLC, a nonprofit company dedicated to bringing low-cost generic medicines and biosimilars to U.S. patients, today announced the availability of two new products: insulin glargine-yfgn ...

As Americans struggle to afford groceries and utilities, a new study finds that three Ohio cities are among the most ...

The new year will begin with some first-of-their-kind laws in several states. Hawaii will become the first state to raise its ...

SaveHealth reports that insulin therapy is crucial for diabetes management, with various options available, including rapid- and long-acting insulins.

CivicaScript, a nonprofit generic drug company, has launched insulin glargine-yfgn and ustekinumab-aauz, expanding its national portfolio of low-cost treatments. The insulin product, which is ...

The personal finance company WalletHub issued its latest survey of cities where people spend the most and least on health ...

Abbreviated new drug application filings have declined to 600 in the financial year 2025 (ending in September) versus 740 in ...

Generic drugmaker Viatris has become the first company to secure FDA approval for a biosimilar product that is considered completely interchangeable with the reference product – namely Sanofi's ...

In 2025, healthcare was one of the main drivers of the U.S. economy. So much so, in fact, that the Centers for Medicare and Medicaid Services (CMS) expects health spending to reach $5.6 trillion by ...

There's a reason "health" and "wealth" rhyme. They may be the same thing. The personal finance company WalletHub issued its ...